{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-177636","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.281643+00:00","generated_at":"2026-06-25T00:24:02.387832+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Acumen shareholders elect all director nominees and ratify E&Y as auditor at annual meeting","bullets":["All three Class I director nominees elected: Kimberlee C. Drapkin, Jeffrey Ives (Ph.D.), Sean Stalfort; broker non-votes of 5,658,008.","Ratification of Ernst & Young as independent auditor received 34,702,393.73 votes for, 761.18 against, 165 abstentions.","Approximately 85.69% of outstanding shares (34,703,319.92 of 40,496,512) were present or represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-177636","json":"https://secwatch.observer/filing/0001193125-22-177636.json","markdown":"https://secwatch.observer/filing/0001193125-22-177636.md","text":"https://secwatch.observer/filing/0001193125-22-177636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/0001193125-22-177636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/d371573d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:24:02.387832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}